drugset / Trial / NCT05411965
A Study to Evaluate the Pharmacokinetics After Administration of BR3003 and Co-administration of BR3003B and BR3003C.
RandomizedCrossoverOpen-labelTreatment
Summary
To perform a comparative evaluation on the pharmacokinetics and the safety after administration of "BR3003" and co-administration of "BR3003B" and "BR3003C" in healthy adults.
Timeline
- Start
- 2022-04-28
- Primary completion
- 2022-07-03
- Completion
- 2022-07-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dapagliflozin | Small molecule | 10 mg | Oral |
| Subject | Pioglitazone | Small molecule | 30 mg | Oral |